MIRA INFORM REPORT
|
Report No. : |
350561 |
|
Report Date : |
18.11.2015 |
IDENTIFICATION DETAILS
|
Name : |
ALKEM LABORATORIES LIMITED (w.e.f. 21.08.2001) |
|
|
|
|
Formerly Known
As : |
ALKEM LABORATORIES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Alkem House, Devashish, Senapati Bapat Marg, Lower Parel, Mumbai –
400013, Maharashtra |
|
Tel. No.: |
91-22-39829999 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
08.08.1973 |
|
|
|
|
Com. Reg. No.: |
11-174201 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 119.565 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U00305MH1973PLC174201 |
|
|
|
|
IEC No.: |
0388161442 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCA9521E |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer, Exporter and Importer of Active Pharmaceutical
Ingredients, Generic, Branded, Nutraceuticals Products and also in Investing
and Real Estate Business. |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
|
MIRA’s Rating : |
A (70) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject was incorporated in the year 1973 and it is manufacturer, exporter
and importer of active pharmaceutical ingredients, generic, branded,
nutraceuticals products. For the financial year ended 2014, company has reported 16.75% sales
turnover growth as compared to previous sales turnover and it has maintained
decent profitability margins at 16.28 % during the year under a review. Rating continue to reflect company’s established position in the
formulations market in India supported by its strong financial base along
with adequate net worth position and favorable liquidity profile of the
company. However, rating strengths are partially offset by the company’s
considerable revenue dependence on the acute therapeutic segment, and its
limited export revenue, which keeps its operating margin subdued. Trade relations are reported as decent. Payments are reported to be
regular and as per commitment. In view of aforesaid, the subject company regarded as promising
business partner for medium to long term business dealings. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long term rating AA |
|
Rating Explanation |
High degree of safety and very low credit risk |
|
Date |
31.08.2015 |
|
Rating Agency Name |
CRISIL |
|
Rating |
Short term rating A1+ |
|
Rating Explanation |
Very strong degree of safety and carry lowest credit risk |
|
Date |
31.08.2015 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2015.
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Ms. Divya Mevani |
|
Designation : |
General Manager / Assistant Company Secretary |
|
Contact No.: |
91-22-39829675 |
LOCATIONS
|
Registered Office : |
Alkem House, Devashish, Senapati Bapat Marg, Lower Parel, Mumbai –
400013, Maharashtra, India |
|
Tel. No.: |
91-22-39829999 |
|
Fax No.: |
91-22-24862789 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 1 : |
C 6/1, MIDC Industrial
Estate, Taloja, District Raigad, |
|
|
|
|
Factory 2 : |
N. H. No. 8, Village Naugama,
Jhagadia, District – Bharuch, |
|
|
|
|
Factory 3: |
333/1, Kachigam, |
|
|
|
|
Factory 4: |
167/2, Amaliya, Dabhel,
|
|
|
|
|
Factory 5: |
289/290, GIDC,
Ankleshwar , District – Bharuch, |
|
|
|
|
Factory 6: |
167/1, Amaliya, Dabhel, Daman, India |
|
|
|
|
Factory 7: |
Village Thane – Baddi, Th- Nalagarh, District – Solan, Himachal Pradesh, India |
|
|
|
|
Factory : |
Also Located At: · Sikkim ·
Daman |
DIRECTORS
As on 31.03.2015
|
Name : |
Mr. Singh Sandeep Satish Kumar |
|
Designation : |
Managing director |
|
Address : |
403 /404 Richoux Society, Jn Of St. Joseph Rd And Kantw Bandra Mumbai -400050, Maharashtra, India |
|
Date of Birth/Age : |
23.07.1982 |
|
Date of Appointment : |
31.10.2012 |
|
DIN No.: |
01277984 |
|
|
|
|
Name : |
Mr. Dhananjay Kumar Singh |
|
Designation : |
Managing director |
|
Address : |
Flat No 16, 16th Floor, Vasudha Apartment, Worli, Mumbai –
400025, Maharashtra, India |
|
Date of Birth/Age : |
29.07.1962 |
|
Qualification : |
B.A |
|
Date of Appointment : |
01.04.2014 |
|
DIN No.: |
00739153 |
|
|
|
|
Name : |
Mr. Balmiki Prasad Singh |
|
Designation : |
Whole-time director |
|
Address : |
1st Floor, Room No. 101, Westmore II, Pochkhanwala Road,
Worli, Mumbai – 400018, Maharashtra, India |
|
Date of Birth/Age : |
26.12.1954 |
|
Qualification : |
B.com |
|
Date of Appointment : |
01.04.2011 |
|
DIN No.: |
00739856 |
|
|
|
|
Name : |
Samprada Singh |
|
Designation : |
Whole-time director |
|
Address : |
Budha Colony, Boring Canal Road, Patna – 800001, Bihar, India |
|
Date of Birth/Age : |
02.05.1930 |
|
Qualification : |
B.com |
|
Date of Appointment : |
01.04.2014 |
|
DIN No.: |
00760279 |
|
|
|
|
Name : |
Mr. Basudeo Narayan Singh |
|
Designation : |
Managing director |
|
Address : |
Budha Colony, Boring Canal Road, Patna – 800001, Bihar, India |
|
Date of Birth/Age : |
20.11.1940 |
|
Qualification : |
M.A |
|
Date of Appointment : |
01.04.2014 |
|
DIN No.: |
00760310 |
|
|
|
|
Name : |
Mr. Mritunjaykumar Singh |
|
Designation : |
Whole-time director |
|
Address : |
3-31, Suraiya Apartment, Sir Pochkhanwala Road, Worli, Mumbai –
400025, Maharashtra, India |
|
Date of Birth/Age : |
04.11.1963 |
|
Qualification : |
B.Sc, DAM |
|
Date of Appointment : |
01.04.2014 |
|
DIN No.: |
00881412 |
|
|
|
|
Name : |
Mr. Mangaldas Chhaganlal Shah |
|
Designation : |
Director |
|
Address : |
D-34/310, MIG Gandhi Nagar, Bandra (East), Mumbai – 400051, Maharashtra,
India |
|
Date of Birth/Age : |
04.07.1933 |
|
Qualification : |
B.com |
|
Date of Appointment : |
26.09.2007 |
|
DIN No.: |
01353574 |
|
|
|
|
Name : |
Mr. Arun Kumar Purwar |
|
Designation : |
Director |
|
Address : |
C - 2303/4, Floor - 23, Ashok Tower,, 63/7-4, Dr. SS Rao Road, Parel, Mumbai-400012, Maharashtra, India |
|
Date of Appointment : |
16.03.2015 |
|
DIN No.: |
00026383 |
|
|
|
|
Name : |
Mr. Ranjal Laxmana Shenoy |
|
Designation : |
Director |
|
Address : |
A-2, Kamdar Park Co-Op. HSG. Society Limited, Agar Bazaar, Off Gokhale Road (N), Mumbai-400028, Maharashtra, India |
|
Date of Appointment : |
20.02.2015 |
|
DIN No.: |
00074761 |
|
|
|
|
Name : |
Ms. Sudha Ravi |
|
Designation : |
Director |
|
Address : |
704/A, 7th Floor, Joanna CHS, Manuel Gonsalves Road, Bandra West,, Mumbai-400050, Maharashtra, India |
|
Date of Appointment : |
29.06.2015 |
|
DIN No.: |
06764496 |
|
|
|
|
Name : |
Ms.Sangeeta Kapiljit Singh |
|
Designation : |
Director |
|
Address : |
9-A, Harbour Heights, A-Building,, N. A. Sawant Marg, Colaba, Mumbai, 400005, Maharashtra, India |
|
Date of Appointment : |
29.06.2015 |
|
DIN No.: |
06920906 |
|
|
|
|
Name : |
Mr. Akhouri Maheshwar Prasad |
|
Designation : |
Director |
|
Address : |
158, First Floor, Pataliputra Colony, Patna-800013, Bihar, India |
|
Date of Appointment : |
30.01.2015 |
|
DIN No.: |
07066439 |
KEY EXECUTIVES
|
Name : |
Ms. Divya Mevani |
|
Designation : |
General Manager / Assistant Company Secretary |
|
|
|
|
Name : |
Mr. Manish Abnashi Lal Narang |
|
Designation : |
Secretary |
|
Address : |
B-603, 6th Floor, Mercury Building, Suncity Apartments,
Powai, Mumbai – 400076, Maharashtra, India |
|
Date of Birth/Age : |
31.08.1970 |
|
Date of Appointment : |
16.12.2006 |
|
PAN No.: |
AAHPN6263D |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 18.08.2014
SHAREHOLDING DETAILS FILE ATTACHED
Equity Share Break up (Percentage of Total Equity)
As on 18.08.2014
|
Category |
Percentage |
|
Directors or relatives of Directors |
78.20 |
|
Other top fifty shareholders |
21.80 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer, Exporter and Importer of Active Pharmaceutical Ingredients,
Generic, Branded, Nutraceuticals Products and also in Investing and Real
Estate Business. |
||||||||||||
|
|
|
||||||||||||
|
Products : |
|
||||||||||||
|
|
|
||||||||||||
|
Brand Names : |
Not Available |
||||||||||||
|
|
|
||||||||||||
|
Agencies Held : |
Not Available |
||||||||||||
|
|
|
||||||||||||
|
Exports : |
|
||||||||||||
|
Products : |
Finished goods |
||||||||||||
|
Countries : |
|
||||||||||||
|
|
|
||||||||||||
|
Imports : |
Not Available |
||||||||||||
|
|
|
||||||||||||
|
Terms : |
|
||||||||||||
|
Selling : |
Cash / L/C / Cheque / Credit |
||||||||||||
|
|
|
||||||||||||
|
Purchasing : |
Cash / L/C / Cheque / Credit |
PRODUCTION STATUS NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Information declined by the management |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
·
State Bank of India, Worli, Mumbai, Maharashtra,
India |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Financial
institution : |
Member Secretary Single Window Clearance Agency, Department Of Industries, Baddi, Tehsil - Nalagarh, Solan - 173205, Himachal Pradesh, India |
|
Auditors : |
|
|
Name : |
R.S. Sanghai and Associates Chartered Accountants |
|
Address : |
A/403, Raj Kaman
Heights, Raj Kamal Marg, Dr. S S Rao Marg, Lower Parel, Mumbai – 400012,
Maharashtra, India |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AAHPS2141R |
|
|
|
|
Memberships : |
-- |
|
|
|
|
Collaborators : |
-- |
|
|
|
|
Subsidiary
companies : |
· Alkem Laboratories (NIG) Limited, Nigeria · Alkem Laboratories (Pty) Limited, South Africa · Alkem Pharma GMBH, Germany · Alkem Laboratories Corporation, Philippines · S & B Holdings B.V., Netherlands · Pharmacor Pty Limited, Australia · Angelic Holdings Sa, Swaziland · Ascends Laboratories SDN BHD, Malaysia · Ascends Laboratories Spa, Chile · Enzene Biosciences Limited, · Alkem Laboratories Korea Inc · Pharmacor Limited, Kenya · S & B Pharma Inc, United States · The Pharmanetwork LLP, Kazakhstan · TPN Italia, SRS, Italy · T P N China, Inc, China |
|
|
|
|
Fellow Subsidiary companies : |
· The Pharmanetwork, LLC, United States · Ascend Laboratories LLC, United States |
|
|
|
|
Enterprises which are
owned, or have significant
influence of or are partners with Key management
personnel and their relatives |
· Cachet Pharmaceuticals Private Limited · Indchemie Health Specialities Private Limited · Galpha Laboratories Limited · Travelon Services Private Limited |
CAPITAL STRUCTURE
As on 18.08.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
50,000,000 |
Equity Shares |
Rs.10/- each |
Rs. 500.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
23,913,000 |
Equity Shares |
Rs.10/- each |
Rs. 239.130
Million |
|
|
|
|
|
As on 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15,000,000 |
Equity Shares |
Rs.10/- each |
Rs. 150.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
11,956,500 |
Equity Shares |
Rs.10/- each |
Rs. 119.565
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are in
Rupees Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
119.565 |
119.565 |
119.565 |
|
(b) Reserves & Surplus |
27780.354 |
23619.090 |
18935.714 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
27899.919 |
23738.655 |
19055.279 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
539.235 |
922.845 |
1271.875 |
|
(b) Deferred tax liabilities (Net) |
609.081 |
498.968 |
364.093 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
276.824 |
314.114 |
342.639 |
|
Total Non-current
Liabilities (3) |
1425.140 |
1735.927 |
1978.607 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
8544.736 |
11032.827 |
6763.501 |
|
(b) Trade
payables |
2760.402 |
2575.405 |
2624.136 |
|
(c) Other
current liabilities |
1225.177 |
1112.974 |
967.163 |
|
(d) Short-term
provisions |
465.329 |
286.257 |
435.288 |
|
Total Current
Liabilities (4) |
12995.644 |
15007.463 |
10790.088 |
|
|
|
|
|
|
TOTAL |
42320.703 |
40482.045 |
31823.974 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
8348.911 |
7552.942 |
5781.828 |
|
(ii)
Intangible Assets |
38.167 |
42.533 |
15.213 |
|
(iii)
Capital work-in-progress |
706.813 |
725.375 |
852.119 |
|
(iv)
Intangible assets under development |
0.000 |
139.507 |
0.000 |
|
(b) Non-current Investments |
6098.323 |
2356.607 |
499.864 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
5042.468 |
4050.467 |
2899.594 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
20234.682 |
14867.431 |
10048.618 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a) Current
investments |
3309.582 |
3437.276 |
3221.998 |
|
(b)
Inventories |
5045.533 |
4428.546 |
2971.322 |
|
(c) Trade
receivables |
2968.764 |
3018.027 |
2575.567 |
|
(d) Cash
and cash equivalents |
8908.082 |
12569.163 |
11308.371 |
|
(e) Short-term
loans and advances |
1385.312 |
1278.310 |
857.367 |
|
(f) Other
current assets |
468.748 |
883.292 |
840.731 |
|
Total
Current Assets |
22086.021 |
25614.614 |
21775.356 |
|
|
|
|
|
|
TOTAL |
42320.703 |
40482.045 |
31823.974 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
27083.971 |
23278.951 |
19533.962 |
|
|
|
Other Income |
1693.444 |
1692.357 |
1348.382 |
|
|
|
TOTAL (A) |
28777.415 |
24971.308 |
20882.344 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
7513.953 |
6483.429 |
5863.247 |
|
|
|
Purchases of Stock-in-Trade |
4358.430 |
3753.121 |
2587.925 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
(526.368) |
(1233.260) |
(587.020) |
|
|
|
Employees benefits expense |
4421.547 |
3684.115 |
2758.388 |
|
|
|
Other expenses |
7188.663 |
6032.498 |
4901.848 |
|
|
|
TOTAL
(B) |
22956.225 |
18719.903 |
15524.388 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
5821.190 |
6251.405 |
5357.956 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
842.741 |
792.155 |
534.731 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
4978.449 |
5459.250 |
4823.225 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
427.302 |
360.152 |
279.402 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
4551.147 |
5099.098 |
4543.823 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
110.113 |
137.799 |
289.011 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
4441.034 |
4961.299 |
4254.812 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
371.00 |
415.00 |
356.00 |
|
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Current Maturities of Long term debt |
479.320 |
434.280 |
254.375 |
|
Cash generated from operations |
2143.203 |
6590.838 |
2150.708 |
|
Net Cash (used)/ generated Operating Activities |
1058.060 |
5523.872 |
1184.674 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin (PAT / Sales) |
(%) |
16.40 |
21.31 |
21.78 |
|
|
|
|
|
|
|
Operating Profit Margin (PBIDT/Sales) |
(%) |
21.49 |
26.85 |
27.43 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
12.81 |
13.68 |
14.91 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.16 |
0.21 |
0.24 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.34 |
0.52 |
0.44 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.70 |
1.71 |
2.02 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Share Capital |
119.565 |
119.565 |
119.565 |
|
Reserves & Surplus |
18935.714 |
23619.090 |
27780.354 |
|
Net
worth |
19055.279 |
23738.655 |
27899.919 |
|
|
|
|
|
|
long-term borrowings |
1271.875 |
922.845 |
539.235 |
|
Short term borrowings |
6763.501 |
11032.827 |
8544.736 |
|
Current Maturities Of Long-Term
Debts |
254.375 |
434.280 |
479.320 |
|
Total
borrowings |
8289.751 |
12389.952 |
9563.291 |
|
Debt/Equity
ratio |
0.435 |
0.522 |
0.343 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
19533.962 |
23278.951 |
27083.971 |
|
|
|
19.172 |
16.345 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Million) |
(Rs.
In Million) |
(Rs.
In Million) |
|
Sales |
19533.962 |
23278.951 |
27083.971 |
|
Profit |
4254.812 |
4961.299 |
4441.034 |
|
|
21.78% |
21.31% |
16.40% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of establishment |
Yes |
|
2] |
Constitution of the entity Incorporation
details |
Yes |
|
3] |
Locality of the entity |
Yes |
|
4] |
Premises details |
No |
|
5] |
Buyer visit details |
-- |
|
6] |
Contact numbers |
Yes |
|
7] |
Name of the person contacted |
Yes |
|
8] |
Designation of contact person |
Yes |
|
9] |
Promoter’s background |
Yes |
|
10] |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11] |
Pan Card No. of Proprietor / Partners |
Yes |
|
12] |
Voter Id Card No. of Proprietor / Partners |
No |
|
13] |
Type of business |
Yes |
|
14] |
Line of Business |
Yes |
|
15] |
Export/import details (if applicable) |
Yes |
|
16] |
No. of employees |
No |
|
17] |
Details of sister concerns |
Yes |
|
18] |
Major suppliers |
No |
|
19] |
Major customers |
No |
|
20] |
Banking Details |
Yes |
|
21] |
Banking facility details |
Yes |
|
22] |
Conduct of the banking account |
-- |
|
23] |
Financials, if provided |
Yes |
|
24] |
Capital in the business |
Yes |
|
25] |
Last accounts filed at ROC, if applicable |
Yes |
|
26] |
Turnover of firm for last three years |
Yes |
|
27] |
Reasons for variation <> 20% |
-- |
|
28] |
Estimation for coming financial year |
No |
|
29] |
Profitability for last three years |
Yes |
|
30] |
Major shareholders, if available |
Yes |
|
31] |
External Agency Rating, if available |
Yes |
|
32] |
Litigations that the firm/promoter
involved in |
Yes |
|
33] |
Market information |
-- |
|
34] |
Payments terms |
Yes |
|
35] |
Negative Reporting by Auditors in the
Annual Report |
No |
|
LITIGATION DETAILS |
|||||
|
Bench:- Bombay |
|||||
|
Presentation
Date:- 26/02/2015 |
|||||
|
Lodging No. : |
CEXAL/52/2015 |
Failing Date:- |
26/02/2015 |
Reg. No.:- |
CEXA/154/2015 |
|
Reg. Date:- |
29/07/2015 |
|
|
|
|
|
Petitioner:- |
THE COMMISSIONER OF CENTRAL EXCISE, CUSTOM SERVICES TAX – DAMAN |
Respondent:- |
ALKEM LABORATORIES LIMITED |
||
|
Petn.Adv:- |
PRADEEP SHIVNARAIN JETLY (I3289) |
Resp.Adv.:- |
0(0) |
||
|
District:- |
OUTSIDE MAHARASHTRA |
||||
|
Bench:- |
DIVISION |
|
|
||
|
Status:- |
Pre-Admission |
Category:- |
CENTRAL EXCISE APPEAL (CEXA) |
||
|
Next Date:- |
23/11/2015 |
Stage:- |
FOR REJECTION [ORIGINAL SIDE MATTERS] |
||
|
Coram:- |
· HON'BLE SHRI JUSTICE S.C. DHARMADHIKARI · HON'BLE SHRI JUSTICE B.P. COLABAWALLA |
Stage:- |
FOR REJECTION [ORIGINAL SIDE MATTERS] |
||
|
Last Date:- |
10/07/2015 |
|
|
||
|
Last Coram:- |
REGISTRAR(OS)/PROTHONOTARY AND SR. MASTER |
|
|
||
|
Act. : |
Central Excise & Salt Act |
Under Section:- |
35G |
||
INDEX
OF CHARGES
|
S.No. |
Charge ID |
Date of Charge Creation/Modification |
Charge amount secured |
Charge Holder |
Address |
Service Request Number (SRN) |
|
1 |
10578739 |
02/06/2015 |
2,205,000,000.00 |
Citi Bank N.A. |
First International Financial Centre, Plot Nos., C-54 &
C-55, G-Block, BKC, Bandra East, Mumbai, Maharashtra - 400051, INDIA |
C58309089 |
|
2 |
10578225 |
27/02/2015 |
2,000,000,000.00 |
DENA BANK |
Maheshwari Udyan Branch, 467-A, Vora Bhavan, Matunga , Mumbai - 400 019.,
Mumbai, Maharashtra - 400019, INDIA |
C58072190 |
|
3 |
10483471 |
06/03/2014 |
901,414,059.00 |
DBS BANK LIMITED |
Upper DLF Capitol Point, Gr & 1st Floor,, Baba Kharak Singh Marg,
Connaught Place, New Delhi, Delhi - 110001, INDIA |
B98848278 |
|
4 |
10072610 |
12/09/2007 |
3,000,000.00 |
MEMBER SECRETARY SINGLE WINDOW CLEARANCE AGENCY |
DEPARTMENT OF INDUSTRIES, BADDI, TEHSIL - NALAGAR H, SOLAN,
Himachal Pradesh - 173205, INDIA |
A25615204 |
|
5 |
90264437 |
08/07/2010 * |
1,750,000,000.00 |
STATE BANK OF INDIA |
INDUSTRIAL FINANCE BRANCH, SHIVSAGAR ESTATE,WORLI -(S), MUMBAI,
Maharashtra- 400018, INDIA |
A88704135 |
* Date of charge modification
UNSECURED LOAN
|
PARTICULARS |
31.03.2014 (Rs.
in Million) |
31.03.2013 (Rs.
in Million) |
|
Short-term
borrowings |
|
|
|
Working capital loans from banks (Working Capital Loan from banks In Foreign Currency carries Interest rate In the range of 1.10% to 2.00% and those In Indian Rupees carries Interest rate in the range of 9% to 12% P.A.) |
1411.154 |
2541.079 |
|
Deposits from others |
92.527 |
94.160 |
|
Loans and advances from related |
657.913 |
460.908 |
|
Total |
2161.594 |
3096.147 |
FIXED ASSETS
Tangible Assets
Ø Land
Ø Building
Ø Office building
Ø Factory building
Ø Building
Ø Plant and
machinery
Ø Office equipments
Ø Factory equipments
Ø Computer
equipments
Ø Other equipments
Ø Furniture and
fixtures
Ø Vehicles
Ø Motor vehicles
Ø Livestock
Intangible Assets
Ø Computer software
Ø Knowhow
Ø Patents trademarks
design
Ø Commercial
contractual rights
NEWS
Joining the IPO rush, drug maker Alkem Laboratories plans to raise an estimated Rs 15000.000-35000.000 Million through an initial public offering in one of the biggest offerings in the pharma space in a long time.
The move follows the blockbuster IPO of Syngene International, biotechnology major Biocon's research arm.
With this public offer, the company is expected to be valued at around Rs 150000.000 Million.
"Alkem will soon file its draft paper with capital market regulator Securities and Exchange Board of India (Sebi) to float an IPO," sources said.
The company, which has a significant presence in the country, plans to expand its footprint internationally. Mumbai-headquartered Alkem, which was founded in 1973, began operations as a healthcare marketing company.
Since then, it has grown to become the country's seventh largest pharmaceutical company with sales revenues exceeding USD 500 million with a CAGR of 16 per cent over the last five years.
In the pharma space, Pune-based Emcure Pharmaceuticals pulled out its proposed IPO application in June last year. It was planning to garner around Rs 5000.000 Million.
After a quiet 2014, IPO market is buzzing again as 24 companies have filed draft papers with Sebi, while some others, including GVK Airport, are in the process to file their initial papers.
While nine IPOs have already hit the market this year, many others are currently in the pipeline, including operators of popular brands like IndiGo, Cafe Coffee Day and Matrix. These nine firms have raised nearly Rs 45500.000 Million via IPOs.
In comparison, a total of six IPOs had hit the market in the
entire 2014 and together garnered just Rs 15280.000 Million. Recently, the Rs
5500.000 Million IPO of Syngene International wasover-subscribed 32.03
times.
The flurry of activities also comes at a time when Sebi has announced a slew of
fresh reforms in the IPO space, including halving the listing period to six
days.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.65.98 |
|
|
1 |
Rs.100.10 |
|
Euro |
1 |
Rs.70.34 |
INFORMATION DETAILS
|
Information
Gathered by : |
DPA |
|
|
|
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared
by : |
JYTK |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
8 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILITY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
8 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
8 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
70 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.